Other languages Scholar Rock Holding Corporation

Equities

SRRK

US80706P1030

Real-time Estimate Cboe BZX Other stock markets 11:41:44 2024-05-29 am EDT			5-day change	1st Jan Change
9.91 ^USD	-4.07%		-15.41%	-47.31%

May. 28	Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology Annual Meeting	CI
May. 23	Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology Annual Meeting	May. 28
Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity	May. 22
Scholar Rock Holding Corporation Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity	May. 22
Scholar Rock Shares Fall on Wider-Than-Expected Q1 Loss	May. 07
Scholar Rock Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07
Scholar Rock Shares Rise After Raymond James Initiates Coverage	Mar. 28
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19
Scholar Rock Announces Management Appointments	Feb. 15
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management	Feb. 06
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity	Jan. 23
Adipositas-Mittel führen zu Muskelverlust - Pharmafirmen steuern gegen	Jan. 22
Scholar Rock Holding Insider Sold Shares Worth $448,444, According to a Recent SEC Filing	Dec. 15
Scholar Rock Holding Insider Sold Shares Worth $436,820, According to a Recent SEC Filing	Dec. 08
Scholar Rock Holding Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07
Scholar Rock Holding Insider Sold Shares Worth $438,039, According to a Recent SEC Filing	Nov. 06
Scholar Rock's Experimental Drug Shows Anti-Tumor Activity in Early-Stage Trial	Nov. 03
Scholar Rock, Inc. Presents New Data from Phase 1 Dragon Trial Showing Promising Anti-Tumor Activity in Anti-Pd-1 Resistant Metastaticcc Patients and Supporting Srk-181 Continued Tolerability	Nov. 03
Scholar Rock Announces to Present Clinical and Biomarker Data from the Phase 1 Dragon Trial At the Sitc 38Th Annual Meeting	23-10-19
Scholar Rock Holding Insider Bought Shares Worth $15,000,000, According to a Recent SEC Filing	23-10-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Scholar Rock Holding Corporation

Equities

SRRK

US80706P1030

Other languages

Filters